Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.12−0.25 (-10.57%)
Close on Nov 13, 2026Market cap $171.87MP/E –Yield –
Eledon Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Eledon Pharmaceuticals's enterprise value was $127.18M on Nov 11, 2026, against $4.21M a year earlier. Over the last 5 years it ranged from -$43.11M to $187.76M, with a median of $6.77M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $127.18M | – |
| 2025 | Dec 31, 2025 | -$2.98M | -103.3% |
| 2024 | Dec 31, 2024 | $91.47M | – |
| 2023 | Dec 29, 2023 | -$17.22M | – |
| 2022 | Dec 30, 2022 | -$34.52M | – |
| 2021 | Dec 31, 2021 | -$30.95M | – |
| 2020 | Dec 31, 2020 | -$94.83M | – |
| 2019 | Dec 31, 2019 | -$3.29M | – |
| 2018 | Dec 31, 2018 | -$1.25M | -113.9% |
| 2017 | Dec 29, 2017 | $9.02M | – |
| 2016 | Dec 30, 2016 | -$1.69M | – |
| 2015 | Dec 31, 2015 | -$27.08M | – |
| 2014 | Dec 31, 2014 | -$95.51M | – |
See a number that looks wrong?